EC Number   |
Title |
Organism |
|---|
   3.1.6.13 | Direct assay of iduronate-2-sulfatase for Hunter disease using UPLC-tandem mass spectrometry and fluorogenic substrate |
Homo sapiens |
| 3.1.6.13 | Insights into Hunter syndrome from the structure of iduronate-2-sulfatase |
Homo sapiens |
| 3.1.6.13 | Production and characterization of a human lysosomal recombinant iduronate-2-sulfatase produced in Pichia pastoris |
Homo sapiens |
| 3.1.6.13 | Quantification of the enzyme activities of iduronate-2-sulfatase, N-acetylgalactosamine-6-sulfatase and N-acetylgalactosamine-4-sulfatase using liquid chromatography-tandem mass spectrometry |
Homo sapiens |
| 3.1.6.13 | Structural basis of mucopolysaccharidosis type II and construction of a database of mutant iduronate 2-sulfatases |
Homo sapiens |
| 3.1.6.13 | "Supercharged Cells" for delivery of recombinant human iduronate-2-sulfatase |
Homo sapiens |
| 3.1.6.13 | A novel functional role of iduronate-2-sulfatase in zebrafish early development |
Danio rerio |
| 3.1.6.13 | Analysis of normal and mutant iduronate-2-sulphatase conformation |
Homo sapiens |
| 3.1.6.13 | Characterization of a novel p.S305P and a known c.1006+5G>C splice site mutation in human iduronate-2-sulfatase associated with mucopolysaccharidosis type II |
Homo sapiens |
| 3.1.6.13 | Characterization of iduronate sulphatase mutants affecting N-glycosylation sites and the cysteine-84 residue |
Homo sapiens |
